Current Assets Alterar Data
Aceragen USD 5.64M 12.23M 2023-03
Alterity Therapeutics Limited AUD 27.05M 6.16M 2023-06
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Capricor Therapeutics USD 29.53M 9.4M 2023-09
Celldex Therapeutics USD 431.69M 185.76M 2023-12
Clal Biotechnology ILS 16.64M 4.52M 2022-12
Compugen USD 60.27M 9.13M 2023-09
CSL USD 9.26B 342.6M 2023-06
Eli Lilly USD 23.01B 1.68B 2023-09
Grifols EUR 5.02B 210.6M 2023-09
Incyte USD 4.65B 242.74M 2023-12
Intrexon USD 92.99M 12.64M 2023-09
Lumos Pharma USD 47.45M 8.54M 2023-09
Merck USD 31.95B 1.98B 2023-09
Nektar Therapeutics USD 399.02M 42.03M 2023-09
Pfizer USD 74.01B 665M 2023-09
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Vascular Biogenics USD 20.94M 6.03M 2023-09



Lumos Pharma Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.